Endometrial carcinosarcoma
Giorgio Bogani(Università Cattolica del Sacro Cuore), Bradley J. Monk(Creighton University), Francisco José Cândido dos Reis(Universidade de São Paulo), Ròbert Póka(Gynecologic Oncology Group), Hannelore Denys(Ghent University Hospital), Robert L. Coleman(Weston Park Cancer Centre), Marta Bini(Fondazione IRCCS Istituto Nazionale dei Tumori), Masashi Takano(National Defense Medical College Hospital), Biagio Paolini(Fondazione IRCCS Istituto Nazionale dei Tumori), Diane Provencher(Centre Hospitalier de l’Université de Montréal), Gianfranco Zannoni(Agostino Gemelli University Polyclinic), Se Ik Kim(Seoul National University), Nicole Concin(Innsbruck Medical University), Natalie Y.L. Ngoi(National University Cancer Institute, Singapore), Mary McCormack(University College Hospital), Yakir Segev(Technion – Israel Institute of Technology), Giuseppe Caruso(Istituti di Ricovero e Cura a Carattere Scientifico), Michelle Vaughan(Environment Canterbury), Kazuhiro Takehara(Shikoku Cancer Center), Jae‐Weon Kim(Seoul National University Hospital), Mario M. Leitão(Memorial Sloan Kettering Cancer Center), Pauline Wimberger(University Hospital Carl Gustav Carus), Philippe Morice(Université Paris-Sud), Takayuki Enomoto(Niigata University), Ludovico Muzii(Policlinico Umberto I), Satoru Sagae(Cardiovascular Center Hokkaido Ohno Hospital), Ignace Vergote(KU Leuven), David S.P. Tan(National University of Singapore), Domenica Lorusso(Agostino Gemelli University Polyclinic), Pedro T. Ramírez(The University of Texas MD Anderson Cancer Center), Pierluigi Benedetti Panici(Sapienza University of Rome), Isabelle Ray‐Coquard(Centre Léon Bérard), Vicky Makker(Memorial Sloan Kettering Cancer Center), Andrea Mariani(Mayo Clinic), Violante Di Donato(Policlinico Umberto I), Sandro Pignata(Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"), Francesco Raspagliesi(Fondazione IRCCS Istituto Nazionale dei Tumori), Nicoletta Colombo(University of Milan), Nadeem R. Abu‐Rustum(Memorial Sloan Kettering Cancer Center)
Cited by 95
Related Papers
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
|Journal of Clinical Oncology|2000|2.3k
ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
|International Journal of Gynecological Cancer|2020|1.9k
2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial
|The Lancet|2007|1.5k
Sensitive and specific multi-cancer detection and localization using methylation signatures in cell-free DNA
|Annals of Oncology|2020|1.5k